Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Originalspråkengelska
TidskriftOncotarget
Volym8
Utgåva34
Sidor (från-till)56338-56350
Antal sidor13
ISSN1949-2553
DOI
StatusPublicerad - 22 aug 2017
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3122 Cancersjukdomar
  • 3111 Biomedicinska vetenskaper

Citera det här

@article{b7b6c01ad32c423790cc10db9446971f,
title = "Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing",
keywords = "multiple myeloma, functional screening, drug sensitivity and resistance testing, precision medicine, high-risk myeloma, LOW-DOSE DEXAMETHASONE, GLUCOCORTICOID-RECEPTOR, RISK-STRATIFICATION, TARGETED THERAPY, WORKING GROUP, SINGLE-AGENT, PHASE-II, CELLS, PANOBINOSTAT, COMBINATION, 3122 Cancers, 3111 Biomedicine",
author = "Majumder, {Muntasir Mamun} and Raija Silvennoinen and Pekka Anttila and David Tamborero and Samuli Eldfors and Bhagwan Yadav and Riikka Karjalainen and Heikki Kuusanmaki and Juha Lievonen and Alun Parsons and Minna Suvela and Esa Jantunen and Kimmo Porkka and Heckman, {Caroline A.}",
year = "2017",
month = "8",
day = "22",
doi = "10.18632/oncotarget.17630",
language = "English",
volume = "8",
pages = "56338--56350",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "34",

}

TY - JOUR

T1 - Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing

AU - Majumder, Muntasir Mamun

AU - Silvennoinen, Raija

AU - Anttila, Pekka

AU - Tamborero, David

AU - Eldfors, Samuli

AU - Yadav, Bhagwan

AU - Karjalainen, Riikka

AU - Kuusanmaki, Heikki

AU - Lievonen, Juha

AU - Parsons, Alun

AU - Suvela, Minna

AU - Jantunen, Esa

AU - Porkka, Kimmo

AU - Heckman, Caroline A.

PY - 2017/8/22

Y1 - 2017/8/22

KW - multiple myeloma

KW - functional screening

KW - drug sensitivity and resistance testing

KW - precision medicine

KW - high-risk myeloma

KW - LOW-DOSE DEXAMETHASONE

KW - GLUCOCORTICOID-RECEPTOR

KW - RISK-STRATIFICATION

KW - TARGETED THERAPY

KW - WORKING GROUP

KW - SINGLE-AGENT

KW - PHASE-II

KW - CELLS

KW - PANOBINOSTAT

KW - COMBINATION

KW - 3122 Cancers

KW - 3111 Biomedicine

U2 - 10.18632/oncotarget.17630

DO - 10.18632/oncotarget.17630

M3 - Article

VL - 8

SP - 56338

EP - 56350

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 34

ER -